PRECIGEN INC's ticker is PGEN and the CUSIP is 74017N105. A total of 139 filers reported holding PRECIGEN INC in Q3 2023. The put-call ratio across all filers is 0.23 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,928,383 | +31.8% | 2,766,467 | +6.7% | 0.00% | – |
| Q2 2023 | $2,981,355 | +26.8% | 2,592,483 | +16.9% | 0.00% | – |
| Q1 2023 | $2,351,324 | -61.4% | 2,218,230 | -44.7% | 0.00% | – |
| Q4 2022 | $6,094,182 | +49.0% | 4,009,330 | +107.8% | 0.00% | – |
| Q3 2022 | $4,090,000 | +54.0% | 1,929,338 | -2.6% | 0.00% | – |
| Q2 2022 | $2,655,000 | -44.3% | 1,981,664 | -12.3% | 0.00% | – |
| Q1 2022 | $4,769,000 | -81.7% | 2,260,339 | -67.8% | 0.00% | -100.0% |
| Q4 2021 | $26,030,000 | +7.6% | 7,016,045 | +44.7% | 0.00% | 0.0% |
| Q3 2021 | $24,201,000 | -35.1% | 4,849,807 | -15.2% | 0.00% | -50.0% |
| Q2 2021 | $37,282,000 | -21.3% | 5,718,162 | -16.8% | 0.00% | -33.3% |
| Q1 2021 | $47,365,000 | +50.2% | 6,874,445 | +122.4% | 0.00% | +50.0% |
| Q4 2020 | $31,534,000 | +140.2% | 3,091,605 | -17.6% | 0.00% | +100.0% |
| Q3 2020 | $13,128,000 | +77.2% | 3,750,882 | +152.6% | 0.00% | 0.0% |
| Q2 2020 | $7,410,000 | -41.6% | 1,484,910 | -60.2% | 0.00% | 0.0% |
| Q1 2020 | $12,693,000 | – | 3,733,122 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Patient Capital Management, LLC | 13,753,176 | $19,529,510 | 1.15% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 2,078,220 | $2,951,072 | 0.60% |
| EMFO, LLC | 425,000 | $603,500 | 0.57% |
| Opaleye Management Inc. | 928,500 | $1,318,470 | 0.43% |
| First Washington CORP | 646,575 | $918,137 | 0.37% |
| Fore Capital, LLC | 426,791 | $606,043 | 0.26% |
| SANDERS MORRIS HARRIS LLC | 410,000 | $582,200 | 0.12% |
| MSD Partners, L.P. | 960,000 | $1,363,200 | 0.11% |
| Virtus ETF Advisers LLC | 79,754 | $113,251 | 0.07% |
| CHIRON CAPITAL MANAGEMENT, LLC | 55,850 | $79,307 | 0.07% |